FDA scientists remain unconvinced of peptide safety and benefits In recent years, the FDA has warned Americans about the risks of injecting peptides like BPC-157 and TB-500, another compound set for review Thursday
flexible ratios Cycle driver Whichever compound titrates more slowly Cagrilintide Loading 0.25 2.4 mg over ~16 weeks Frequency Once weekly Maintenance 2.4 mg Route SubQ Semaglutide Loading 0.25 2.4 mg over ~16 weeks Frequency Once weekly Maintenance 2.4 mg Route SubQ Weekly Schedule Example (Maintenance) Same day each week Cagrilintide 2.4 mg SubQ + Semaglutide 2.4 mg SubQ Use separate syringes for each compound
When in doubt, use compounds sequentially rather than simultaneously, rotating through different mechanisms during consecutive cycles
For most individuals, a combination of daily topical use and occasional micro-infusion provides exceptional anti-aging benefits without invasive procedures
fill-finish & sterile handling Lyophilized for long-term stability Tamper-evident vial What is GHK-Cu: GHK-Cu is a naturally occurring copper-binding peptide studied because it regulates gene expression related to tissue repair, collagen synthesis, and anti-inflammatory signaling, making it important in research on skin, hair, and regenerative biology
What the published literature on BPC-157 / GHK-Cu / TB-500 blend actually measures The literature on this combination is, as far as the peer-reviewed record goes, nonexistent